Nivolumab plus Ipilimumab in Non-Small-Cell Lung Cancer

被引：0
|
作者：
Bersanelli, Melissa [1 ]
Tiseo, Marcello [1 ]
Banna, Giuseppe L. [2 ]
机构：
[1] Univ Parma, Parma, Italy
[2] United Lincolnshire Hosp NHS Trust, Lincoln, England
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：874 / 875
页数：2
相关论文
共 50 条
  • [31] Who Should Receive the Chemotherapy-Free Combination of Nivolumab Plus Ipilimumab as the First-Line Treatment of Advanced Non-Small-Cell Lung Cancer?
    Li, Ziming
    Lu, Shun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (06) : 1172 - +
  • [32] Nivolumab-induced asthma in a patient with non-small-cell lung cancer
    Maeno, K.
    Fukuda, S.
    Oguri, T.
    Niimi, A.
    ANNALS OF ONCOLOGY, 2017, 28 (11) : 2891 - 2891
  • [33] Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer (NSCLC)
    Rogado, J.
    Pacheco-Barcia, V.
    Fenor De la Maza, M. D.
    Serra, J. M.
    Toquero, P.
    Vera, B.
    Obispo, B.
    Mondejar, R.
    Ballesteros, A.
    Donnay, O.
    Colomer, R.
    Sanchez-Torres, J. M.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1915 - S1916
  • [34] Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer
    Provencio, Mariano
    Nadal, Ernest
    Gonzalez-Larriba, Jose L.
    Martinez-Marti, Alex
    Bernabe, Reyes
    Bosch-Barrera, Joaquim
    Casal-Rubio, Joaquin
    Calvo, Virginia
    Insa, Amelia
    Ponce, Santiago
    Reguart, Noemi
    de Castro, Javier
    Mosquera, Joaquin
    Cobo, Manuel
    Aguilar, Andres
    Vivanco, Guillermo Lopez
    Camps, Carlos
    Lopez-Castro, Rafael
    Moran, Teresa
    Barneto, Isidoro
    Rodriguez-Abreu, Delvys
    Serna-Blasco, Roberto
    Benitez, Raquel
    Aguado de la Rosa, Carlos
    Palmero, Ramon
    Hernando-Trancho, Florentino
    Martin-Lopez, Javier
    Cruz-Bermudez, Alberto
    Massuti, Bartomeu
    Romero, Atocha
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (06): : 504 - 513
  • [35] Nivolumab-refractory patients with advanced non-small-cell lung cancer
    Costantini, A.
    Fallet, V.
    Corny, J.
    Friard, S.
    Chouaid, C.
    Duchemann, B.
    Giroux-Leprieur, E.
    Taillade, L.
    Doucet, L.
    Brosseau, S.
    Wislez, M.
    Tredaniel, J.
    Cadranel, J.
    LUNG CANCER, 2019, 130 : 128 - 134
  • [36] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
    Borghaei, H.
    Paz-Ares, L.
    Horn, L.
    Spigel, D. R.
    Steins, M.
    Ready, N. E.
    Chow, L. Q.
    Vokes, E. E.
    Felip, E.
    Holgado, E.
    Barlesi, F.
    Kohlhaeufl, M.
    Arrieta, O.
    Burgio, M. A.
    Fayette, J.
    Lena, H.
    Poddubskaya, E.
    Gerber, D. E.
    Gettinger, S. N.
    Rudin, C. M.
    Rizvi, N.
    Crino, L.
    Blumenschein, G. R.
    Antonia, S. J.
    Dorange, C.
    Harbison, C. T.
    Finckenstein, F. Graf
    Brahmer, J. R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17): : 1627 - 1639
  • [37] New targeted treatments for non-small-cell lung cancer - role of nivolumab
    Zago, Giulia
    Muller, Mirte
    van den Heuvel, Michel
    Baas, Paul
    BIOLOGICS-TARGETS & THERAPY, 2016, 10 : 103 - 117
  • [38] Treatment of non-small-cell lung cancer after progression on nivolumab or pembrolizumab
    Freeman, A. T.
    Lesperance, M.
    Wai, E. S.
    Croteau, N. S.
    Fiorino, L.
    Geller, G.
    Brooks, E. G.
    Poonja, Z.
    Fenton, D.
    Irons, S.
    Ksienski, D.
    CURRENT ONCOLOGY, 2020, 27 (02) : 76 - 82
  • [39] Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancer
    Ang, Yvonne L. E.
    Lim, Joline S. J.
    Soo, Ross A.
    ONCOTARGETS AND THERAPY, 2016, 9 : 3187 - 3195
  • [40] Rituximab for nivolumab plus ipilimumab-induced encephalitis in a small-cell lung cancer patient
    Ito, M.
    Fujiwara, S.
    Fujimoto, D.
    Mori, R.
    Yoshimura, H.
    Hata, A.
    Kohara, N.
    Tomii, K.
    ANNALS OF ONCOLOGY, 2017, 28 (09) : 2318 - 2319
12345